M.Sc. & Ph.D. (Biotechnology)

Dr. Abhishek Pandeya earned his Ph.D. in Biotechnology from Babasaheb Bhimrao Ambedkar University, Lucknow, and 3 years post doctoral experience in CSIR- Indian Institute of Toxicology Research, Lucknow. He has more 10 years of research experience in molecular biology, RNA interference, miRNA studies, stem cell biology, iPSCs technology, 3D organoid modeling, in vitro toxicology, Flow cytometry, Immunocytochemistry, Confocal Microscopy and neurodegenerative disorders. Additionally, his focus is on extracellular vesicle-based nanocarriers and organoid models for therapeutic interventions in neurodegeneration. He worked as a Project Research Scientist-1 in CSIR- Indian Institute of Toxicology Research, Lucknow, and worked on Amyotrophic Lateral Sclerosis. He has published 11 research papers, 4 book chapters, holds 2 patents, and is a recipient of an ICMR fellowship. Dr. Pandeya has demonstrated excellence throughout his career. He is a life member of multiple professional societies, including the International Society of Neurochemistry, American Society of Microbiology, International Society for Advancement of Cytometry, Indian Immunology Society, the Indian Academy of Neurosciences, and the Cytometry Society of India. Passionate about translational research, he continues to mentor young scientists while contributing to advancing Stem Cell technologies, precision medicine and neurodegenerative disease research. 

Thrust Area: 

• RNA Silencing 
• microRNA-mediated Host- Pathogen Interactions 
• Human Stem Cells and Regeneration Biology 
• 3D Organoid Models for Disease Mechanisms 
• In vitro Toxicology 
• Neurodegenerative Disorders 
• Cell Culture and Differentiation 

Publications:

Research Articles: (11) 

• Pankhi Vatsa, Ankita Srivastava, Ankur Kumar Srivastava, Abhishek Pandeya, Akash Singh, and Aditya Bhushan Pant. (2025). Mesenchymal stem cell secretome restores monocrotophos induced toxicity in human neural progenitor cells. Biochemical and Biophysical Research Communications, 769, 1–25. DOI: 10.1016/j.bbrc.2025.151987. (Impact factor: 2.30) 
• Uzair A. Ansari, Ankita Srivastava, Ankur K. Srivastava, Abhishek Pandeya, Pankhi Vatsa, Renu Negi, Akash Singh, and Aditya B. Pant. (2025). Targeting TDP-43 proteinopathy in hiPSC-derived mutated hNPCs with mitoxantrone drugs and miRNAs. Pharmaceutics, 17(4), 410. DOI: 10.3390/pharmaceutics17040410. (Impact Factor: 5.50) 
• Renu Negi, Ankita Srivastava, Ankur Kumar Srivastava, Pankhi Vatsa, Uzair Ahmed Ansari, Bushra Khan, Harshita Singh, Abhishek Pandeya, and Aditya Bhushan Pant. (2024). Proteomic-miRNA biomics profile reveals 2D cultures of human iPSC-derived neural progenitor cells more sensitive than 3D spheroid system against the experimental exposure to arsenic. Molecular Neurobiology, 61, 5754–5770. DOI: 10.1007/s12035-024-03924-z. (Impact Factor: 5.78) 
• Raj Kumar Khalko#, Abhishek Pandeya#, Sangeeta Saxena, and Sunil Babu Gosipatala. (2023). HCMV miR-UL70-3p downregulates the rapamycin-induced autophagy by targeting the autophagy-related protein 9A (ATG9A). International Review of Immunology, 43(4), 197–210. DOI: 10.1080/08830185.2023.2296488. (Impact Factor: 4.88) 
• Ankita Srivastava, Ankur Kumar Srivastava, Abhishek Pandeya, and Aditya Bhushan Pant. (2023). Pesticide mediated silent neurotoxicity and its unmasking: An update on recent progress. Toxicology, 500, 153665. DOI: 10.1016/j.tox.2023.153665. (Impact Factor: 4.80). 
• Renu Negi, Ankita Srivastava, Ankur Kumar Srivastava, Abhishek Pandeya, Pankhi Vatsa, Uzair Ahmed Ansari, and Aditya Bhushan Pant. (2023). Proteome architecture of human-induced pluripotent stem cell-derived three-dimensional organoids as a tool for early diagnosis of neuronal disorders. Indian Journal of Pharmacology, 55(2), 108–118. DOI: 10.4103/ijp.ijp_56_23. (Impact Factor: 2.833) 
• Abhishek Pandeya#, Raj Kumar Khalko#, Manish Kumar, and Sunil Babu Gosipatala. (2022). HCMV-miR-UL148D regulates the Staurosporine-induced apoptosis by targeting the Endoplasmic Reticulum to Nucleus Signaling 1 (ERN1). PLoS One, 17(9), e0275072. DOI: 10.1371/journal.pone.0275072. (Impact factor: 3.752) 
• Pranesh Kumar, Mohit Kumar, Anurag Kumar Gautam, Archana Bharti Sonkar, Abhishek Verma, Amita Singh, Raquibun Nisha, Umesh Kumar, Dinesh Kumar, Tarun Mahata, Bolay Bhattacharya, Biswanath Maity, Abhishek Pandeya, Sunil Babu Gosipatala, and Sudipta Saha. (2022). Ameliorative effect of fluvoxamine against colon carcinogenesis via COX-2 blockade with oxidative and metabolic stress reduction at the cellular, molecular and metabolic levels. BBA Advances, 2, 100046. DOI:  10.1016/j.bbadva.2022.100046.  (Impact Factor: 1.55) 
• Abhishek Pandeya, Raj Kumar Khalko, Anup Mishra, Sukhveer Singh, Nishant Singh, Sanjay Yadav, Sudipta Saha, Sangeeta Saxena, and Sunil Babu Gosipatala. (2022). Human cytomegalovirus miR-UL70-3p downregulates the H2O2-induced apoptosis by targeting the modulator of apoptosis-1. International Journal of Molecular Sciences, 23, 18. DOI: 10.3390/ijms23010018. (Impact Factor: 6.203) 
• Bharti Kotarya, Abhishek Pandeya, Raj Kumar Khalko, Anup Mishra, Arti Priyadarshini, N. Vijaya, Manoj Kumar Singh, Sudipta Saha, and Sunil Babu Gosipatala. (2021). Prospects of SARS-CoV-2 vaccines and their landscape. Journal of Experimental Biology and Agricultural Sciences, 8(spl1), S246–S263. DOI: 10.18006/2020.8(Spl-1-SARS-CoV-2).S246.S263. (Impact Factor: 0.577). 
• Sunil G. Babu, Abhishek Pandeya, Neelam Verma, Nikita Shukla, R. Venkatesh Kumar, and Sangeeta Saxena. (2014). Role of HCMV miR-UL70-3p and miRUL148D in overcoming the cellular apoptosis. Molecular and Cellular Biochemistry, 014, 2049–2058. DOI: 10.1007/s11010-014-2049-8. (Impact Factor: 3.578) 

(# Share equal Contributions) 

Book Chapters: (04) 

• Abhishek Pandeya and Aditya Bhushan Pant. (2025). Application of flow cytometry in elucidating the intricate mechanism of neurotoxicity. In Flow Cytometry: Applications in Cellular and Molecular Toxicology. Springer Nature, Singapore; 141-177 (First Author) (ISBN: 978-9819797578) 
• Sneha Kumari, Abhishek Pandeya, Raj Kumar Khalko, Ranbir Chander Sobti, and Sunil Babu Gosipatala. (2024). Viral miRNAs role as diagnostic, prognostic biomarkers for cancer and infectious diseases. In Biomarkers in Cancer Detection and Monitoring of Therapeutics. Academic Press; 199-221. (Co-author) (ISBN: 978-0323951159) 
• Abhishek Pandeya, Raj Kumar Khalko, Bharti Kotarya, Hema, Jitendra Kumar Yadav, Sudipta Saha, Ranbir Chander Sobti, and Sunil Babu Gosipatala. (2023). Human papillomavirus (HPV) – molecular epidemiology of infection and its associated diseases. In Biomedical Research, Medicine and Disease. Taylor & Francis; 337-361. (First Author) (ISBN: 978-1003220404) 
• Ranbir Chander Sobti, Bharti Kotarya, Abhishek Pandeya, Raj Kumar Khalko, Sudipta Saha, Y. Vasudeva, and Sunil Babu Gosipatala. (2021). Corona viruses: Emergence, evolution and recurrence. In Delineating Health and Health System: Covid-19 Mechanistic Approach; 1-40 (Co-author). (ISBN: 978-9811651052) 

Patents: (02) 

• Award collaborator’s Indian Design Patent for “Nebulizer for Targeted Drug Delivery” with Design number 398863-001 dated 31/10/2023.  
• Application filed for Indian Design Patent for “Equipment for prediction of Anti-inflamatory, Analgesic and Antioxidant activity of extract”